ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	6/14	492/7206	0.00018391485799
ko04622	RIG-I-like receptor signaling pathway	3/14	62/7206	0.000206385234191
ko05222	Small cell lung cancer	3/14	89/7206	0.000600796635163
ko04064	NF-kappa B signaling pathway	3/14	96/7206	0.00074983218879
ko04620	Toll-like receptor signaling pathway	3/14	100/7206	0.00084470613222
ko05162	Measles	3/14	120/7206	0.00143372500769
ko04623	Cytosolic DNA-sensing pathway	2/14	41/7206	0.0027526462115
ko05160	Hepatitis C	3/14	153/7206	0.00287655808141
ko04621	NOD-like receptor signaling pathway	3/14	157/7206	0.00309539961854
ko00073	Cutin, suberine and wax biosynthesis	1/14	2/7206	0.00388214540168
ko04210	Apoptosis	3/14	180/7206	0.00455406885908
ko04151	PI3K-Akt signaling pathway	4/14	390/7206	0.0054806360884
ko05169	Epstein-Barr virus infection	3/14	206/7206	0.00663879008733
ko05140	Leishmaniasis	2/14	75/7206	0.00897070639583
ko05212	Pancreatic cancer	2/14	83/7206	0.0109037627556
ko05220	Chronic myeloid leukemia	2/14	85/7206	0.0114135450129
ko05218	Melanoma	2/14	85/7206	0.0114135450129
ko04657	IL-17 signaling pathway	2/14	87/7206	0.0119337798882
ko05133	Pertussis	2/14	87/7206	0.0119337798882
ko04917	Prolactin signaling pathway	2/14	87/7206	0.0119337798882
ko04668	TNF signaling pathway	2/14	120/7206	0.0219597264119
ko04010	MAPK signaling pathway	3/14	321/7206	0.02211103197
ko05145	Toxoplasmosis	2/14	126/7206	0.0240601207472
ko05142	Chagas disease (American trypanosomiasis)	2/14	130/7206	0.0255052600324
ko04380	Osteoclast differentiation	2/14	134/7206	0.0269856528088
ko04722	Neurotrophin signaling pathway	2/14	160/7206	0.037430093995
ko05161	Hepatitis B	2/14	173/7206	0.0431566560051
ko05224	Breast cancer	2/14	174/7206	0.0436103402714
ko00531	Glycosaminoglycan degradation	1/14	23/7206	0.0438083697876
ko05206	MicroRNAs in cancer	2/14	177/7206	0.0449824248202
ko04218	Cellular senescence	2/14	177/7206	0.0449824248202
ko04080	Neuroactive ligand-receptor interaction	3/14	423/7206	0.045063501593
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/14	182/7206	0.0473055437013
ko05168	Herpes simplex infection	2/14	182/7206	0.0473055437013
ko05152	Tuberculosis	2/14	187/7206	0.049673226237